Skip to main content

Table 2 Semiquantitative values for PSMA uptake and mpMRI

From: Quantitative imaging parameters to predict the local staging of prostate cancer in intermediate- to high-risk patients

Semiquantitative parameters Total EPD +  EPD− p-value
SUVmax(mean ± SD) 14.2 ± 10 16.7 ± 10.4 12.4 ± 9.2 0.081
PSMAvol(mean ± SD) 6.7 ± 8.4 10.4 ± 10.7 3.9 ± 4.2 0.004
PSMAtot(mean ± SD) 53.2 ± 82.5 86.7 ± 109.5 28.4 ± 37.1 0.008
ADCmin(mean ± SD) 0.534* ± 0.252 0.525** ± 0.209 0.539 ± 0.276 0.818
ADCmean(mean ± SD) 0.942* ± 0.232 0.922** ± .218 0.956 ± 0.238 0.546
mpMRI LCC (mean ± SD) 20.4 ± 16.5 26.6 ± 18.9 15.8 ± 12.6 0.009
mpMRI volume (mean ± SD) 3.0 ± 6.0 4.3 ± 8 2.1 ± 3.6 0.162
  1. Statistically significant p-values are marked by bold font
  2. EPD extraprostatic disease, SUV standardized uptake value, max maximum, min minimum, SD standard deviation, ADC apparent diffusion coefficient, LCC longest capsular contact
  3. *72/73 patients assessable
  4. **30/31 patients assessable